The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Osteosarcoma
Open accessAbstract
The successful treatment of patients with osteosarcoma requires close cooperation within an experienced multidisciplinary team including pediatric or medical oncologists, surgeons, pathologists and radiologists. Therefore, therapy should be performed in specialized centers able to provide access to the full spectrum of care. As in other rare malignancies, treatment should be administered within prospective multicenter trials. Therapy must include complete surgical removal of all detectable tumor sites as well as multiagent chemotherapy. The chemotherapy regimen should include several or all of the following four drugs: doxorubicin, high-dose methotrexate with leukovorin-rescue, cisplatin and ifosfamide. Preoperative (neoadjuvant) plus postoperative (adjuvant) polychemotherapy should be preferred, because it allows preparation for safe surgery and preparation of the appropriate prosthesis for the individual patient. The choice of the postponed definitive surgical procedure should be influenced by the anatomical site of the primary tumor, its relationship to neighboring structures, such as vessels and nerves, age and growth potential of the patient, and probably also by the response of the tumor to preoperative chemotherapy. A major, as yet unsolved, problem is the dismal prognosis for patients with unresectable or relapsed osteosarcomas. Novel approaches are needed in order to improve their prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
World Health Organization Classification of Tumours
Fletcher, C., van den Berg, A., & Molenaar, I. (2002) · Cited by 7,079
A System for the Surgical Staging of Musculoskeletal Sarcoma
ENNEKING, W. F., SPANIER, S. S., & GOODMAN, M. A. (1980) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198011000-00013 · Cited by 2,500
Bielack, S. S., Kempf-Bielack, B., Delling, G., Exner, G. U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.776 · Cited by 2,393 · cited 2×
“The most common primary sites are the distal femur, the proximal tibia, and the proximal humerus, with 50% originating around the knee [3, 7, 8].”
BackgroundSelf-citationSoft-Tissue Sarcomas, Breast Cancer, and Other Neoplasms: A Familial Syndrome?
LI, F. P., & FRAUMENI, J. F. (1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-71-4-747 · Cited by 1,509
Link, M. P., Goorin, A. M., Miser, A. W., Green, A. A., Pratt, C. B., Belasco, J. B., Pritchard, J., Malpas, J. S., Baker, A. R., Kirkpatrick, J. A., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606193142502 · Cited by 1,204
Kager, L., Zoubek, A., Pötschger, U., Kastner, U., Flege, S., Kempf-Bielack, B., Branscheid, D., Kotz, R., Salzer-Kuntschik, M., Winkelmann, W., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.132 · Cited by 934
Self-citationLipshultz, S. E., Lipsitz, S. R., Mone, S. M., Goorin, A. M., Sallan, S. E., Sanders, S. P., Orav, E. J., Gelber, R. D., & Colan, S. D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506293322602 · Cited by 803
Meyers, P. A., Schwartz, C. L., Krailo, M. D., Healey, J. H., Bernstein, M. L., Betcher, D., Ferguson, W. S., Gebhardt, M. C., Goorin, A. M., Harris, M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.14.0095 · Cited by 752
Common Musculoskeletal Tumors of Childhood and Adolescence
Arndt, C. A. S., & Crist, W. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907293410507 · Cited by 657 · cited 4×
“The most common primary sites are the distal femur, the proximal tibia, and the proximal humerus, with 50% originating around the knee [3, 7, 8].”
BackgroundInfluentialKempf-Bielack, B., Bielack, S. S., Jürgens, H., Branscheid, D., Berdel, W. E., Exner, G. U., Göbel, U., Helmke, K., Jundt, G., Kabisch, H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.063 · Cited by 643
Self-citationPrimary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery
Rosen, G., Marcove, R. C., Caparros, B., Nirenberg, A., Kosloff, C., & Huvos, A. G. (1979) · Cancer · doi:10.1002/1097-0142(197906)43:6<2163::aid-cncr2820430602>3.0.co;2-s · Cited by 592
Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial.
Eilber, F., Giuliano, A., Eckardt, J., Patterson, K., Moseley, S., & Goodnight, J. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.1.21 · Cited by 529
Goorin, A. M., Schwartzentruber, D. J., Devidas, M., Gebhardt, M. C., Ayala, A. G., Harris, M. B., Helman, L. J., Grier, H. E., & Link, M. P. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.165 · Cited by 395
Lewis, I. J., Nooij, M. A., Whelan, J., Sydes, M. R., Grimer, R., Hogendoorn, P. C. W., Memon, M. A., Weeden, S., Uscinska, B. M., van Glabbeke, M., et al. (2007) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djk015 · Cited by 346
Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study.
Winkler, K., Beron, G., Kotz, R., Salzer-Kuntschik, M., Beck, J., Beck, W., Brandeis, W., Ebell, W., Erttmann, R., & Göbel, U. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.6.617 · Cited by 345
Osteosarcoma of the Pelvis: Experience of the Cooperative Osteosarcoma Study Group
Ozaki, T., Flege, S., Kevric, M., Lindner, N., Maas, R., Delling, G., Schwarz, R., von Hochstetter, A. R., Salzer-Kuntschik, M., Berdel, W. E., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.142 · Cited by 342
Self-citationAmputation and Adriamycin in Primary Osteosarcoma
Cortes, E. P., Holland, J. F., Wang, J. J., Sinks, L. F., Blom, J., Senn, H., Bank, A., & Glidewell, O. (1974) · New England Journal of Medicine · doi:10.1056/nejm197411072911903 · Cited by 317
Postrelapse Survival in Osteosarcoma of the Extremities: Prognostic Factors for Long-Term Survival
Ferrari, S., Briccoli, A., Mercuri, M., Bertoni, F., Picci, P., Tienghi, A., Del Prever, A. B., Fagioli, F., Comandone, A., & Bacci, G. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.141 · Cited by 316
Osteosarcoma of the spine: Experience of the Cooperative Osteosarcoma Study Group
Ozaki, T., Flege, S., Liljenqvist, U., Hillmann, A., Delling, G., Salzer‐Kuntschik, M., Jürgens, H., Kotz, R., Winkelmann, W., & Bielack, S. S. (2002) · Cancer · doi:10.1002/cncr.10258 · Cited by 283
Self-citationStiller, C. A., Bielack, S. S., Jundt, G., & Steliarova-Foucher, E. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.05.015 · Cited by 283
Self-citationSurgical options for children with osteosarcoma
Grimer, R. J. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)01734-1 · Cited by 242
Bielack, S. S., Kempf-Bielack, B., Branscheid, D., Carrle, D., Friedel, G., Helmke, K., Kevric, M., Jundt, G., Kühne, T., Maas, R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.2305 · Cited by 238
Self-citationOsteosarcoma: The COSS Experience
Bielack, S., Jürgens, H., Jundt, G., Kevric, M., Kühne, T., Reichardt, P., Zoubek, A., Werner, M., Winkelmann, W., & Kotz, R. (2009) · Cancer Treatment and Research · doi:10.1007/978-1-4419-0284-9_15 · Cited by 209
Self-citationHILLMANN, A., HOFFMANN, C., GOSHEGER, G., KRAKAU, H., & WINKELMANN, W. (1999) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199904000-00003 · Cited by 207
Jaffe, N., Farber, S., Traggis, D., Geiser, C. F., Kim, B., Das, L. M. V., Frauenberger, G., Djerassi, I., & Cassady, J. R. (1973) · Cancer · doi:10.1002/1097-0142(197306)31:6<1367::aid-cncr2820310611>3.0.co;2-6 · Cited by 190
Meyer, J. S., Nadel, H. R., Marina, N., Womer, R. B., Brown, K. L. B., Eary, J. F., Gorlick, R., Grier, H. E., Randall, R. L., Lawlor, E. R., et al. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21596 · Cited by 180 · cited 1×
“The evaluation of a patient with suspected osteosarcoma begins with a full history, physical examination, and plain radiographs [10].”
BackgroundThe Role of Radiotherapy in Oseosarcoma
Schwarz, R., Bruland, Ø. S., Cassoni, A. M., Schomberg, P. J., & Bielack, S. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0284-9_7 · Cited by 167
Self-citationSkip Metastases in Osteosarcoma: Experience of the Cooperative Osteosarcoma Study Group
Kager, L., Zoubek, A., Kastner, U., Kempf‐Bielack, B., Potratz, J. C., Kotz, R. I., Exner, G. U., Franzius, C., Lang, S., Maas, R., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2978 · Cited by 139
Self-citationRossi, R., Gödde, A., Kleinebrand, A., Riepenhausen, M., Boos, J., Ritter, J., & Jürgens, H. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.1.159 · Cited by 135
Self-citationPrognosis for patients who have osteosarcoma with skip metastasis.
Wuisman, P. I. J. M., & Enneking, W. F. (1990) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-199072010-00010 · Cited by 122
Survival of children with bone sarcoma in Europe since 1978
Stiller, C. A., Craft, A. W., & Corazziari, I. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00004-1 · Cited by 122
Harris, M. B., Cantor, A. B., Goorin, A. M., Shochat, S. J., Ayala, A. G., Ferguson, W. S., Holbrook, T., & Link, M. P. (1995) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950240205 · Cited by 110
cis-Dichlorodiammineplatinum (II) in advanced osteogenic sarcoma.
Ochs, J. J., Freeman, A. I., Douglass, H. O., Ds, H., Mindell, E. R., & Lf, S. (1978) · PubMed · Cited by 108
International Collaboration is Feasible in Trials for Rare Conditions: The EURAMOS Experience
Marina, N. M., Bielack, S., Whelan, J. S., Smeland, S., Krailo, M., Sydes, M. R., Butterfaß‐Bahloul, T., Calaminus, G., & Bernstein, M. L. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0284-9_18 · Cited by 102
Self-citationSecond malignant neoplasms in long‐term survivors of osteosarcoma
Aung, L., Gorlick, R. G., Shi, W., Thaler, H. T., Shorter, N. A., Healey, J. H., Huvos, A. G., & Meyers, P. A. (2002) · Cancer · doi:10.1002/cncr.10861 · Cited by 90
Osteosarcoma Lung Metastases Detection and Principles of Multimodal Therapy
Carrle, D., & Bielack, S. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0284-9_8 · Cited by 69
Self-citationSauerbrey, A., Bielack, S. S., Kempf‐Bielack, B., et al. (2001) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703023 · Cited by 62
Self-citationOsteosarcoma: The Same Old Drugs or More?
Bielack, S., Marina, N. M., Ferrari, S., Helman, L. J., Smeland, S., Whelan, J., & Reaman, G. H. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.1108 · Cited by 60
Self-citationFranzius, C., Schuck, A., & Bielack, S. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.7.1953 · Cited by 49
Self-citationLong-Term Adjuvant Interferon Treatment of Human Osteosarcoma: A pilot study
Strander, H. A., Bauer, H. C. F., Brosjö, O., Fernberg, J.-O., Andris Kreicbergs, A., Nilsonne, U., Silfverswärd, C., Signomklao, T., & Söderlund, V. (1995) · Acta Oncologica · doi:10.3109/02841869509127199 · Cited by 45
Langer, T., Stöhr, W., Paulides, M., Kremers, A., Dörr, H. G., Göbel, U., & Beck, J. D. (2005) · Klinische Pädiatrie · doi:10.1055/s-2005-836503 · Cited by 31
Complexities in Interpretation of Osteosarcoma Clinical Trial Results
Hunsberger, S., Freidlin, B., & Smith, M. A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.3484 · Cited by 30
Cited by
Osteosarcoma: a review of current and future therapeutic approaches
Zhao, X., Wu, Q., Gong, X., Liu, J., & Ma, Y. (2021) · BioMedical Engineering OnLine · doi:10.1186/s12938-021-00860-0 · Cited by 312
Incidence and survival of malignant bone sarcomas in England 1979–2007
Whelan, J., McTiernan, A., Cooper, N., Wong, Y. K., Francis, M., Vernon, S., & Strauss, S. J. (2012) · International Journal of Cancer · doi:10.1002/ijc.26426 · Cited by 255
Proton‐based radiotherapy for unresectable or incompletely resected osteosarcoma
Ciernik, I. F., Niemierko, A., Harmon, D. C., Kobayashi, W., Chen, Y., Yock, T. I., Ebb, D. H., Choy, E., Raskin, K. A., Liebsch, N., et al. (2011) · Cancer · doi:10.1002/cncr.26037 · Cited by 191
Zhang, D., Cheng, S., Tan, J., Xie, J., Zhang, Y., Chen, S., Du, H., Qian, S., Qiao, Y., Peng, F., et al. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.01.032 · Cited by 79
Targeting autophagy enhances atezolizumab-induced mitochondria-related apoptosis in osteosarcoma
Liu, Z., Wang, H., Hu, C., Wu, C., Wang, J., Hu, F., Fu, Y., Wen, J., & Zhang, W. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03449-6 · Cited by 45
Metadata
- Authors
- Ritter, J., & Bielack, S. S.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2010-10
- Volume
- 21
- Pages
- vii320-vii325
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W4235565063
- Cited by
- 1,045
- References
- 42
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.